1. Home
  2. DCTH vs GRVY Comparison

DCTH vs GRVY Comparison

Compare DCTH & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • GRVY
  • Stock Information
  • Founded
  • DCTH 1988
  • GRVY 2000
  • Country
  • DCTH United States
  • GRVY South Korea
  • Employees
  • DCTH N/A
  • GRVY N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • GRVY Business Services
  • Sector
  • DCTH Health Care
  • GRVY Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • GRVY Nasdaq
  • Market Cap
  • DCTH 388.3M
  • GRVY 446.3M
  • IPO Year
  • DCTH N/A
  • GRVY 2005
  • Fundamental
  • Price
  • DCTH $9.83
  • GRVY $57.87
  • Analyst Decision
  • DCTH Strong Buy
  • GRVY
  • Analyst Count
  • DCTH 4
  • GRVY 0
  • Target Price
  • DCTH $24.25
  • GRVY N/A
  • AVG Volume (30 Days)
  • DCTH 1.1M
  • GRVY 17.2K
  • Earning Date
  • DCTH 11-04-2025
  • GRVY 11-13-2025
  • Dividend Yield
  • DCTH N/A
  • GRVY N/A
  • EPS Growth
  • DCTH N/A
  • GRVY N/A
  • EPS
  • DCTH 0.06
  • GRVY 8.59
  • Revenue
  • DCTH $70,240,000.00
  • GRVY $404,804,469.00
  • Revenue This Year
  • DCTH $146.50
  • GRVY N/A
  • Revenue Next Year
  • DCTH $37.19
  • GRVY N/A
  • P/E Ratio
  • DCTH $175.70
  • GRVY $6.74
  • Revenue Growth
  • DCTH 491.35
  • GRVY N/A
  • 52 Week Low
  • DCTH $8.87
  • GRVY $53.12
  • 52 Week High
  • DCTH $18.23
  • GRVY $70.00
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 40.06
  • GRVY 35.33
  • Support Level
  • DCTH $9.15
  • GRVY $57.69
  • Resistance Level
  • DCTH $12.70
  • GRVY $60.86
  • Average True Range (ATR)
  • DCTH 0.73
  • GRVY 1.49
  • MACD
  • DCTH -0.17
  • GRVY 0.04
  • Stochastic Oscillator
  • DCTH 19.16
  • GRVY 29.83

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About GRVY GRAVITY Co. Ltd. American Depository Shares

GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.

Share on Social Networks: